Cara Therapeutics | Stammkapital





Stammkapital Veränderung Datum
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
Assertio Holdings USD 9K 0 2023-12
Cara Therapeutics USD 2K 3K 2025-03
Cassava Sciences USD 48.31M 48.26M 2025-09
Chugai Pharma JPY 1.65B 8K 2025-12
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 93.54M 3.99M 2025-06
CSL USD 576M 19M 2024-12
Grifols EUR 679.73M 0 2025-09
Halozyme Therapeutics USD 117.52M 98K 2025-09
J&J USD 2.41B 584K 2025-09
Neurocrine Biosciences USD 99.7M 700K 2025-09
Pacira USD 44.9M 44.85M 2025-06
Pfizer USD 5.69B 1000K 2025-09
RedHill Biopharma USD 33.3B 20.4B 2025-06
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Vanda Pharmaceuticals USD 58K 0 2024-12


Cara Therapeutics Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.